A Phase 3b Study to Evaluate the Duration of Effect of Bimatoprost SR in Participants with Open-Angle Glaucoma or Ocular Hypertension
Glaucoma treatment study
This study is evaluating the duration and safety of a topical medication (Bimatoprost SR) for people who have OAG or OHT.
- IRB Number: 1904606314
- Research Study Identifier: TX10597
Contact the research team to learn more about this study.
Fields marked with asterisk (*) are required